{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:33:21Z","timestamp":1794360801882,"version":"4.9.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T00:00:00Z","timestamp":1670976000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011624","name":"Marshfield Clinic Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011624","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["75D30121F-00006"],"award-info":[{"award-number":["75D30121F-00006"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["200-2012-53514"],"award-info":[{"award-number":["200-2012-53514"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.vaccine.2022.12.026","type":"journal-article","created":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T01:07:38Z","timestamp":1671152858000},"page":"826-835","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["A broad assessment of covid-19 vaccine safety using tree-based data-mining in the vaccine safety datalink"],"prefix":"10.1016","volume":"41","author":[{"given":"W. Katherine","family":"Yih","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew F.","family":"Daley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Duffy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Fireman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"McClure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Vazquez-Benitez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Weintraub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua T.B.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith C.","family":"Maro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.12.026_b0005","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1001\/jama.2021.15072","article-title":"Surveillance for adverse events after COVID-19 mRNA vaccination","volume":"326","author":"Klein","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2022.12.026_b0010","doi-asserted-by":"crossref","first-page":"283","DOI":"10.15585\/mmwr.mm7008e3","article-title":"First month of COVID-19 vaccine safety monitoring - United States, December 14, 2020-January 13, 2021","volume":"70","author":"Gee","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2022.12.026_b0015","doi-asserted-by":"crossref","first-page":"6017","DOI":"10.1016\/j.vaccine.2021.08.006","article-title":"The next frontier in vaccine safety and VAERS: lessons from COVID-19 and ten recommendations for action","volume":"39","author":"Rizk","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.12.026_b0020","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S1473-3099(22)00054-8","article-title":"Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe","volume":"22","author":"Rosenblum","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2022.12.026_b0025","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1001\/jama.2021.1967","article-title":"Reports of anaphylaxis after receipt of mRNA COVID-19 vaccines in the US\u2014December 14, 2020-January 18, 2021","volume":"325","author":"Shimabukuro","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2022.12.026_b0030","doi-asserted-by":"crossref","unstructured":"Shay DK, Gee J, Su JR, Myers TR, Marquez P, Liu R. Safety monitoring of the Janssen (Johnson & Johnson) COVID-19 vaccine\u2014United States, March-April 2021. MMWR Morb Mortal Wkly Rep 2021;70:680-4. <http:\/\/dx.doi.org\/10.15585\/mmwr.mm7018e2>.","DOI":"10.15585\/mmwr.mm7018e2"},{"key":"10.1016\/j.vaccine.2022.12.026_b0035","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1001\/jama.2021.24110","article-title":"Myocarditis cases reported after mRNA-based COVID-19 vaccination in the US from December 2020 to August 2021","volume":"327","author":"Oster","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2022.12.026_b0040","unstructured":"Goddard K, Lewis E, Fireman B, Weintraub E, Shimabukuro TT, Zerbo O, et al. Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination. Lancet preprint. <https:\/\/papers.ssrn.com\/sol3\/papers.cfm?abstract_id=4059218>."},{"key":"10.1016\/j.vaccine.2022.12.026_b0045","doi-asserted-by":"crossref","unstructured":"See I, Su JR, Lale A, Woo EJ, Guh AY, Shimabukuro TT, et al. US case reports of cerebral venous sinus thrombosis with thrombocytopenia after Ad26.COV2.S vaccination, March 2 to April 21, 2021.JAMA.2021;325:2448\u201356. doi:10.1001\/jama.2021.7517.","DOI":"10.1001\/jama.2021.7517"},{"key":"10.1016\/j.vaccine.2022.12.026_b0050","doi-asserted-by":"crossref","first-page":"651","DOI":"10.15585\/mmwr.mm7017e4","article-title":"Updated recommendations from the Advisory Committee on Immunization Practices for use of the Janssen (Johnson & Johnson) COVID-19 vaccine after reports of thrombosis with thrombocytopenia syndrome among vaccine recipients - United States, April 2021","volume":"70","author":"MacNeil","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2022.12.026_b0055","doi-asserted-by":"crossref","first-page":"e228879","DOI":"10.1001\/jamanetworkopen.2022.8879","article-title":"Incidence of Guillain-Barr\u00e9 syndrome after COVID-19 vaccination in the Vaccine Safety Datalink","volume":"5","author":"Hanson","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.vaccine.2022.12.026_b0060","doi-asserted-by":"crossref","first-page":"90","DOI":"10.15585\/mmwr.mm7103a4","article-title":"Use of the Janssen (Johnson & Johnson) COVID-19 vaccine: Updated interim recommendations from the Advisory Committee on Immunization Practices - United States, December 2021","volume":"71","author":"Oliver","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2022.12.026_b0065","doi-asserted-by":"crossref","first-page":"416","DOI":"10.15585\/mmwr.mm7111a4","volume":"71","author":"Wallace","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2022.12.026_b0070","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/pds.4397","article-title":"Meningococcal conjugate vaccine safety surveillance in the Vaccine Safety Datalink using a tree-temporal scan data mining method","volume":"27","author":"Li","year":"2018","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2022.12.026_b0075","doi-asserted-by":"crossref","unstructured":"Yih WK,* Maro JC,* Nguyen M, Baker MA, Balsbaugh C, Cole DV, et al. Assessment of quadrivalent human papillomavirus vaccine safety using the self-controlled tree-temporal scan statistic signal-detection method in the Sentinel System. Am J Epidemiol 2018;187:1269-76. (*co-primary).","DOI":"10.1093\/aje\/kwy023"},{"key":"10.1016\/j.vaccine.2022.12.026_b0080","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1093\/aje\/kwab022","article-title":"A broad safety assessment of the 9-valent human papillomavirus vaccine","volume":"190","author":"Yih","year":"2021","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2022.12.026_b0085","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/aje\/kwz104","article-title":"Using the self-controlled tree-temporal scan statistic to assess the safety of live attenuated herpes zoster vaccine","volume":"188","author":"Yih","year":"2019","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2022.12.026_b0090","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1093\/aje\/kwac030","article-title":"A broad safety assessment of the recombinant herpes zoster vaccine","volume":"191","author":"Yih","year":"2022","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2022.12.026_b0095","doi-asserted-by":"crossref","first-page":"5390","DOI":"10.1016\/j.vaccine.2014.07.073","article-title":"The vaccine safety datalink: successes and challenges monitoring vaccine safety","volume":"32","author":"McNeil","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.12.026_b0100","unstructured":"Yih WK (co-primary), Maro JC (co-primary), Nguyen M, Baker MA, Balsbaugh C, Cole DV, et al.. Pilot of self-controlled tree-temporal scan analysis for Gardasil vaccine. Final report posted to Sentinel website; September 2016. <https:\/\/www.sentinelinitiative.org\/sites\/default\/files\/Methods\/Mini-Sentinel_PRISM_Pilot-Self-Controlled-Tree-Temporal-Scan-Analysis-Gardasil-Vaccine-Report.pdf>."},{"key":"10.1016\/j.vaccine.2022.12.026_b0105","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1056\/NEJMoa2104983","article-title":"Preliminary findings of mRNA COVID-19 vaccine safety in pregnant persons","volume":"384","author":"Shimabukuro","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2022.12.026_b0110","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1001\/jama.2021.15494","article-title":"Spontaneous abortion following COVID-19 vaccination during pregnancy","volume":"326","author":"Kharbanda","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2022.12.026_b0115","doi-asserted-by":"crossref","first-page":"26","DOI":"10.15585\/mmwr.mm7101e1","article-title":"Receipt of COVID-19 vaccine during pregnancy and preterm or small-for-gestational-age at birth \u2014 Eight integrated health care organizations, United States, December 15, 2020\u2013July 22, 2021","volume":"71","author":"Lipkind","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2022.12.026_b0120","doi-asserted-by":"crossref","unstructured":"DeSilva M, Haapala J, Vazquez-Benitez G, Vesco KK, Daley MF, Getahun, D, et al. Evaluation of acute adverse events after COVID-19 vaccination during pregnancy. N Engl J Med; 2022. <https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMc2205276>.","DOI":"10.1056\/NEJMc2205276"},{"key":"10.1016\/j.vaccine.2022.12.026_b0125","unstructured":"Kulldorff M and Information Management Services, Inc. TreeScan: software for the tree-based scan statistic, version 2.0. Calverton, MD: Information Management Services, Inc.; 2021."},{"key":"10.1016\/j.vaccine.2022.12.026_b0130","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1097\/CCM.0000000000004625","article-title":"Sepsis and coronavirus disease 2019: Common features and anti-inflammatory therapeutic approaches","volume":"48","author":"Beltran-Garc\u00eda","year":"2020","journal-title":"Crit Care Med"},{"key":"10.1016\/j.vaccine.2022.12.026_b0135","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s13054-020-02911-9","article-title":"Acute respiratory failure in COVID-19: is it \u201ctypical\u201d ARDS?","volume":"24","author":"Li","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.vaccine.2022.12.026_b0140","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.15585\/mmwr.mm7043e2","article-title":"COVID-19 vaccination and non-COVID-19 mortality risk\u2014Seven integrated health care organization, United States, December 14, 2020-July 31, 2021","volume":"70","author":"Xu","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22015419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22015419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:18:56Z","timestamp":1777537136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22015419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0264410X22015419"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.12.026","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A broad assessment of covid-19 vaccine safety using tree-based data-mining in the vaccine safety datalink","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.12.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}